Nvs stock price forecast analysts tracking NVS stock price

Analysts tracking NVS stock price forecast cite strong free cash flow and reduced debt ratios as catalysts for a Q2–Q3 trend toward $103–$108, outperforming the healthcare sector index by 2%. In terms of headwinds, certainly, our cost sharing within the system will go up, and that's something we'll have to manage. But on the flipside, our patient support programs also should be adjusted down given the number of patients who would no longer qualify given adjustments, given the IRA being in place. So net-net, we see this as neutral, so slightly negative, but that's already factored in to the guidance that we've given for the long run, so that's already in the 5% out to '28. So no material impact on how we look at the business. The company also announced a substantial share buyback program. Novartis said it is initiating a share buyback of up $10 billion to be completed by year-end 2027. NVS stock price forecast for mid-2024 suggests moderate upside potential, with consensus target set at $